Inventor

HELLERSTEIN MARC K

US34 patents

⚠️ This page may combine multiple inventors who share the name “HELLERSTEIN MARC K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HELLERSTEIN MARC K

UNIV CALIFORNIA

Methods for measuring cellular proliferation and destruction rates in vitro and in vivo

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol

Isotopically labelled DNA

Measurement of protein synthesis rates in humans and experimental systems by use of isotopically labeled water

Methods for screening cellular proliferation using isotope labels

Methods for measuring cellular proliferation and destruction rates in vitro and in vivo

Methods for measuring cellular proliferation and destruction rates in vitro and in vivo

Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis

Methods for identifying the effect of a drug agent on the metabolism of sugars and fats in an individual

Methods for determining the metabolism of sugars and fats in an individual

Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolic products

Measurement of protein synthesis rates in humans and experimental systems by use of isotopically labeled water

Methods for detecting, prognosing, or monitoring a disorder by comparing relative flux rates of two or more biological molecules in vivo

Measurement of protein synthesis rates in humans and experimental systems by use of isotopically labeled water

Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Molecular flux rates through critical pathways measured by stable isotope labeling In Vivo, as biomarkers of drug action and disease activity

Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

HELLERSTEIN MARC K

Method for measuring in vivo synthesis of biopolymers

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry

Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems

Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry

Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products

Monitoring two dimensions of diabetes pathogenesis

Compositions and methods of treatment using modulators of motoneuron diseases

GLAXOSMITHKLINE LLC

Methods for determining total body skeletal muscle mass

BOWEN BENJAMIN P

Metabolic flux measurement, imaging and microscopy